Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.
Grinshpun A, Russo D, Ma W, Verma A, Hermida-Prado F, Sherman S, Gaglia G, Kabraji S, Kirkner G, Hughes ME, Lin NU, Sandusky Z, Nardone A, Guarducci C, Nguyen QD, Santagata S, Nagy Z, Jeselsohn R
NPJ Breast Cancer. 2024 Jun 8;10(1):42. doi: 10.1038/s41523-024-00647-1.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.